Marelius
web2Marelius is a publicly traded US life-sciences company whose UK subsidiary provides regulatory,...
About
Marelius is a publicly traded US life-sciences company whose UK subsidiary provides regulatory, clinical and training support to pharmaceutical and biotechnology programmes. Its wholly owned subsidiary, Marelius Biopharma Group Ltd, offers virtual and in-person instruction, regulatory strategy, clinical-development support and cross-border execution in regulated markets. The service portfolio also includes small-scale contract-manufacturing support, good manufacturing practice compliance and advisory for cell and gene therapy and central nervous system projects. Its regulatory work spans pathways administered by the US Food and Drug Administration, European Medicines Agency and UK Medicines and Healthcare products Regulatory Agency. Marelius Inc. changed its name from Argentum 47 Inc. in November 2025 and trades on OTCID under MBPG.
Explore this sector
Exchange listings
Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.
Marelius profile.
Expert coverage
No published expert evaluations are available for this project yet.
Orbitrum Academy